Assessment of intracellular methotrexate and methotrexate-polyglutamate metabolite concentrations in erythrocytes by ultrafast matrix-assisted laser desorption/ionization triple quadrupole tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 25, Issue 20, 2011, Pages 3063-3070

  Meesters, Roland J W ^a   Den Boer, Ethan ^a   De Jonge, Robert ^a   Lindemans, Jan ^a   Luider, Theo M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; BLOOD; DESORPTION; DISEASES; DRUG PRODUCTS; MASS SPECTROMETRY; PATIENT TREATMENT; PHASE SEPARATION; SIGNAL TO NOISE RATIO;

ANALYTES; HIGH-THROUGHPUT; LYSATES; MATRIX ASSISTED LASER DESORPTION IONIZATION; MATRIXASSISTED LASER DESORPTION-IONIZATION (MALDI); METABOLITE CONCENTRATIONS; POLYGLUTAMATE; RHEUMATOID ARTHRITIS; TRIPLE QUADRUPOLE TANDEM MASS SPECTROMETRY; ULTRA-FAST;

METABOLITES;

EID: 80053283609     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5202     Document Type: Article

References (27)

1. M. Krajinovic, A. Moghrabi,. Pharmacogenetics of methotrexate. Pharmacogenomics 2004, 5, 819.
2. R. B. Warren, R. J. Chalmers, C. E. Griffiths, A. Menter,. Methotrexate for psoriasis in the era of biological therapy. Clin. Exp. Dermatol. 2008, 33, 551.
3. B. N. Cronstein,. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol. Rev. 2005, 57, 163.
4. A. J. Brooks, E. J. Begg, M. Zhang, C. M. Frampton, M. L. Barclay,. Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease. Ther. Drug Monit. 2007, 29, 619.
5. P. Lafforgue, S. Monjanel-Mouterde, A. Durand, J. Catalin, P. C. Acquaviva,. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis. J. Rheumatol. 1995, 22, 844.
6. T. Dervieux, D. Orentas Lein, J. Marcelletti, K. Pischel, K. Smith, M. Walsh, R. Richerson,. HPLC determination of erythrocyte methotrexate polyglutamates after low-dose methotrexate therapy in patients with rheumatoid arthritis. Clin. Chem. 2003, 49, 1632.
7. J. M. Dalrymple, L. K. Stamp, J. L. O'Donnell, P. T. Chapman, M. Zhang, M. L. Barclay,. Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 2008, 58, 3299.
8. P. Angelis-Stoforidis, F. J. Vajda, N. Christophidis,. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis. Clin. Exp. Rheumatol. 1999, 17, 313.
9. H. Hayashi, C. Fujimaki, S. Tsuboi, T. Matsuyama, T. Daimon, K. Itoh,. Application of fluorescence polarization immunoassay for determination of methotrexate-polyglutamates in rheumatoid arthritis patients. Tohoku J. Exp. Med. 2008, 215, 95.
10. C. Y. Kuo, H. L. Wu, H. S. Kou, S. S. Chiou, D. C. Wu, S. M. Wu,. Simultaneous determination of methotrexate and its eight metabolites in human whole blood by capillary zone electrophoresis. J. Chromatogr. A 2003, 1014, 93.
11. L. van Haandel, M. L. Becker, J. S. Leeder, T. D. Williams, J. F. Stobaugh,. A novel high-performance liquid chromatography/mass spectrometry method for improved selective and sensitive measurement of methotrexate polyglutamation status in human red blood cells. Rapid Commun. Mass Spectrom. 2009, 23, 3693.
12. R. J. Meesters, J. J. Van Kampen, R. D. Scheuer, M. E. Van der Ende, R. A. Gruters, T. M. Luider,. Determination of the antiretroviral drug tenofovir in plasma from HIV-infected adults by ultrafast isotope dilution MALDI-triple quadrupole tandem mass spectrometry. J. Mass Spectrom. 2011, 46, 282.
13. R. J. Meesters, R. Cornelissen, R. J. van Klaveren, R. de Jonge, E. den Boer, J. Lindemans, T. M. Luider,. A new ultrafast and high-throughput mass spectrometric approach for the therapeutic drug monitoring of the multi-targeted anti-folate pemetrexed in plasma from lung cancer patients. Anal. Bioanal. Chem. 2010, 398, 2943.
14. R. J. Meesters, J. J. van Kampen, M. L. Reedijk, R. D. Scheuer, L. J. Dekker, D. M. Burger, N. G. Hartwig, A. D. Osterhaus, T. M. Luider, R. A. Gruters,. Ultrafast and high-throughput mass spectrometric assay for therapeutic drug monitoring of antiretroviral drugs in pediatric HIV-1 infection applying dried blood spots. Anal. Bioanal. Chem. 2010, 398, 319.
15. J. J. van Kampen, M. L. Reedijk, P. C. Burgers, L. J. Dekker, N. G. Hartwig, I. E. van der Ende, R. de Groot, A. D. Osterhaus, D. M. Burger, T. M. Luider, R. A. Gruters,. Ultra-fast analysis of plasma and intracellular levels of HIV protease inhibitors in children: a clinical application of MALDI mass spectrometry. PLoS One 2010, 5, e11409.
16. R. J. Meesters, E. den Boer, R. A. Mathot, R. de Jonge, R. J. van Klaveren, J. Lindemans, T. M. Luider,. Ultrafast selective quantification of methotrexate in human plasma by high-throughput MALDI-isotope dilution mass spectrometry. Bioanalysis 2011, 3, 1369.
17. M. Wagner, E. Varesio, G. Hopfgartner,. Ultrafast quantitation of saquinavir in human plasma by matrix-assisted laser desorption/ionization and selected reaction monitoring mode detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 872, 68.
18. P. Hatsis, S. Brombacher, J. Corr, P. Kovarik, D. A. Volmer,. Quantitative analysis of small pharmaceutical drugs using a high repetition rate laser matrix-assisted laser/desorption ionization source. Rapid Commun. Mass Spectrom. 2003, 17, 2303.
19. L. Sleno, D. A. Volmer,. Some fundamental and technical aspects of the quantitative analysis of pharmaceutical drugs by matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19, 1928.
20. R. Rathore, J. Corr, G. Scott, P. Vollmerhaus, K. D. Greis,. Development of an inhibitor screening platform via mass spectrometry. J. Biomol. Screen. 2008, 13, 1007.
21. D. A. Volmer, L. Sleno, K. Bateman, C. Sturino, R. Oballa, T. Mauriala, J. Corr,. Comparison of MALDI to ESI on a triple quadrupole platform for pharmacokinetic analyses. Anal. Chem. 2007, 79, 9000.
22. J. J. van Kampen, P. C. Burgers, R. A. Gruters, A. D. Osterhaus, R. de Groot, T. M. Luider, D. A. Volmer,. Quantitative analysis of antiretroviral drugs in lysates of peripheral blood mononuclear cells using MALDI-triple quadrupole mass spectrometry. Anal. Chem. 2008, 80, 4969.
23. T. Dervieux, R. Zablocki, J. Kremer,. Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis. Rheumatology (Oxford) 2010, 49, 2337.
24. Guidance for Industry: Bioanalytical Method Validation, Center for Drug Evaluation and Research (CDER), 2001.
25. M. L. Becker, L. van Haandel, R. Gaedigk, A. Lasky, M. Hoeltzel, J. Stobaugh, J. S. Leeder,. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations. Arthritis Rheum. 2010, 62, 1803.
26. H. Schroder, K. Fogh,. Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia. Cancer Chemother. Pharmacol. 1988, 21, 145.
27. J. M. Kremer, J. Galivan, A. Streckfuss, B. Kamen,. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum. 1986, 29, 832.